From Concept to Clinic: The Expanding Frontier of Transethosome-Based Drug Delivery Systems
Abstract
Transethosomes are an emerging class of ultra-deformable, lipid-based Nano carriers designed to overcome the limitations of conventional topical and transdermal drug delivery systems. As hybrid vesicles combining the characteristics of transferosomes and ethosomes, they incorporate phospholipids, ethanol, and edge activators to achieve exceptional flexibility, stability, and skin-penetration capability. This review highlights the fundamental principles, composition, and development of transethosomes, along with a detailed discussion of their various preparation techniques and evaluation parameters, including vesicle size, morphology, zeta potential, entrapment efficiency, elasticity, drug release behaviour, and stability. Their unique ability to enhance drug permeation through the stratum corneum enables the effective delivery of molecules ranging from small drugs to large biomacromolecules. Recent advancements demonstrate the broad therapeutic applicability of transethosomes in delivering antifungal, anti-inflammatory, anticancer, antibiotic, hormonal, ant arthritic, antihypertensive, ophthalmic, and cosmetic agents. With improved bioavailability, sustained release profiles, reduced systemic side effects, and high patient compliance, transethosomes represent a highly promising platform for innovative dermal and transdermal drug delivery.
Downloads
References
Seenivasan R, Halagali P, Nayak D, Tippavajhala VK. Transethosomes: a comprehensive review of ultra-deformable vesicular systems for enhanced transdermal drug delivery. AAPS PharmSciTech. 2025;26:41. doi: 10.1208/s12249-024-03035.
Shaji J, Bajaj R. Transethosomes: a new prospect for enhanced transdermal delivery. Int J Pharm Sci Res. 2018;9(7):2681–85. doi:10.13040/IJPSR.0975-8232.9(7).2681-85.
Chowdary P, Padmakumar A, Rengan AK. Exploring the potential of transethosomes in therapeutic delivery: a comprehensive review. MedComm Biomater Appl. 2023;2(4):e59. doi:10.1002/mba2.59.
Ali J, Raza R, Ameen S, Arshad A, Karim F, Akram MW, Shakir L. Transethosomes for transdermal and topical drug delivery. Pak Biomed J. 2022;5(7):578. doi:10.54393/pbmj.v5i7.578.
Bhanushree S, Gopinath E, Ganesh NS, Vineeth Chandy, Nesalin AJ. Transethosomal gel: a perspective approach for topical application. IJPPR Human Journals. 2024;30(2)
Singh JP, Saini G, Singh B, Tiwari G. Nano-formulation approaches to enhance transdermal drug delivery an updated review of nanovesicular carrier “transethosomes”. Pharmaceutical Nanotechnology. 2025;13(4). doi:10.2174/0122117385306281240427073651.
Bhattacharya V, Mishra N, Alagusundaram M. Ultra Deformable Nanotransethosomes: a novel tool to intensify transdermal drug delivery a review. J Pharm Negat Results. 2023;14(3):263. doi: 10.47750/pnr.2023.14.03.263.
Bhattacharya V, Sharma R. Transethosomes: a novel carrier for transcutaneous drug delivery an overview. Int J Pharm Sci & Res. 2023;14(8):3769–78. doi:10.13040/IJPSR.0975-8232.14(8).3769-78.
Pandian C, Sreeja P, Bharath Kumar M, Vasanthakumar A. A review on transethosomal drug delivery system. Int J Pharm Anal Res. 2024;13(4):569–83. doi:10.61096/ijpar.v13.iss4.2024.569-583.
Pandian C, Sreeja P, Bharath Kumar M, Vasanthakumar A. A review on transethosomal drug delivery system. Int J Pharm Anal Res. 2024;13(4):569–83. doi:10.61096/ijpar.v13.iss4.2024.569-583.
Sen N, Khurshid F. A brief review on transethosomes a novel approach towards transdermal drug delivery system. JETIR. 2024;11(6)
Vodnala S, Reddy MS. An overview of Transethosomes: novel nanocarrier for transdermal drug delivery system. GSC Biol Pharm Sci. 2024;26(3):222–31. doi:10.30574/gscbps.2024.26.3.0075)
Talele CR, Talele DR, Shah N, Kumari M, Bhanderi T, Aundhia C. Transethosomes: an innovative approach for drug delivery. Asian J Pharmaceutics. 2023;17(4):615–24. doi:10.22377/ajp.v17i04.5081.
Vodnala S, Reddy MS. Transethosomes: a selective tool for transdermal drug delivery. GSC Biol Pharm Sci. 2024;26(3):222–31. doi:10.30574/gscbps.2024.26.3.0075.
Saieswari K, Gopinath E, Ganesh NS, Vineeth Chandy. Transethosome: a novel drug delivery through skin. IJARIIE. 2022;8(2):16443.
Singh JP, Saini G, Singh B, Tiwari G. Nano-formulation approaches to enhance transdermal drug delivery: an updated review of nanovesicular carrier “transethosomes”. Pharmaceutical Nanotechnology. 2025;13(4): [page numbers]. doi:10.2174/0122117385306281240427073651
Singh P, Sharma S, Verma A, Khan I. Transethosomes: a comprehensive review of ultra-deformable vesicular systems for enhanced transdermal drug delivery. AAPS PharmSciTech. 2025;26:41. doi:10.1208/s12249-024-03035.
Talele CR, Talele DR, Shah N, Kumari M, Bhanderi T, Aundhia C. Transethosomes: An innovative approach for drug delivery. Asian J Pharm. 2023;17(4): 615–24. doi:10.22377/ajp.v17i04.5081
Bhattacharya V, Sharma R. Transethosomes: a novel carrier for transcutaneous drug deliveryan overview. Int J Pharm Sci Res. 2023;14(8):3769–78. doi:10.13040/IJPSR.0975-8232.14(8).3769-78.
Patil SR, Dharashive V, Shafi S, Rudrurkar MN, Kazi AJ, Ritthe PV, et al. Transethosome technology: revolutionizing transdermal drug delivery through innovative formulation strategies. Asian J Pharm Res Dev. 2024;12(3):102–109. doi:10.22270/ajprd.v12i3.1402.
Cevc G, Blume G.Biophysical and skin-penetration properties of ultradeformable vesicles (transfersomes), ethosomes and transethosomes: development, characterization and skin-delivery studies.Int J Pharm. 2015;489(1-2): 23–36. doi:10.1016/j.ijpharm.2015.04.003.
Rosmiati M, Wulantresna D, Emelia R. Transethosomes as vesicular drug delivery: a modified form of ethosomes and transferosomes. Ranah Res J Multidiscip Res Dev. 2024;7(3):1432. doi:10.38035/rrj.v7i3.1432.)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Salunke Harshada, Dr.Hangargekar Sachin, DongareDnyneshwar, Bamankar Akshay, Kharosekar Pooja
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
. 